Jeremy Cetnar

Assistant Professor

  • 745 Citations
  • 10 h-Index
20082018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jeremy Cetnar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Urinary Bladder Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Castration Medicine & Life Sciences
Drug Approval Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

  • 745 Citations
  • 10 h-Index
  • 19 Article
  • 2 Letter
41 Citations (Scopus)

The impact of smoking and tp53 mutations in lung adenocarcinoma patients with targetable mutations—the lung cancer mutation consortium (LCMC2)

Aisner, D. L., Sholl, L. M., Berry, L. D., Rossi, M. R., Chen, H., Fujimoto, J., Moreira, A. L., Ramalingam, S. S., Villaruz, L. C., Otterson, G. A., Haura, E., Politi, K., Glisson, B., Cetnar, J., Garon, E. B., Schiller, J., Waqar, S. N., Sequist, L. V., Brahmer, J., Shyr, Y. & 7 others, Kugler, K., Wistuba, I. I., Johnson, B. E., Minna, J. D., Kris, M. G., Bunn, P. A. & Kwiatkowski, D. J., Mar 1 2018, In : Clinical Cancer Research. 24, 5, p. 1038-1047 10 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Smoking
Mutation
High-Throughput Nucleotide Sequencing
Survival
27 Citations (Scopus)

Immune Checkpoint Inhibitors in Organ Transplant Patients

Kittai, A. S., Oldham, H., Cetnar, J. & Taylor, M., Jul 17 2017, (Accepted/In press) In : Journal of Immunotherapy.

Research output: Contribution to journalArticle

Transplants
Graft Rejection
Death Domain Receptors
Cytotoxic T-Lymphocytes
Organ Transplantation

Is it time to convert the frequency of radiotherapy in small-cell lung cancer?

Mitin, T., Farrell, M., Holland, J., Cetnar, J. & Thomas, C., Oct 1 2017, In : The Lancet Oncology. 18, 10, p. e554

Research output: Contribution to journalLetter

Small Cell Lung Carcinoma
Radiotherapy
1 Citation (Scopus)
Drug Approval
Publications
Food
Pharmaceutical Preparations
Neoplasms
336 Citations (Scopus)

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: A single-group, multicentre, phase 2 trial

Shaw, A. T., Gandhi, L., Gadgeel, S., Riely, G. J., Cetnar, J., West, H., Camidge, D. R., Socinski, M. A., Chiappori, A., Mekhail, T., Chao, B. H., Borghaei, H., Gold, K. A., Zeaiter, A., Bordogna, W., Balas, B., Puig, O., Henschel, V. & Ou, S. H. I., Feb 1 2016, In : The Lancet Oncology. 17, 2, p. 234-242 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Advisory Committees
crizotinib
CH5424802
Population